{"result": "(\"entity\"<|>CELIAC DISEASE<|>EVENT<|>Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, leading to damage in the small intestine and various health complications.)\n##\n(\"entity\"<|>NATIONAL INSTITUTES OF HEALTH<|>ORGANIZATION<|>The National Institutes of Health is a part of the U.S. Department of Health and Human Services and is responsible for biomedical and public health research.)\n##\n(\"entity\"<|>AGA INSTITUTE<|>ORGANIZATION<|>The AGA Institute is a professional organization dedicated to advancing the science and practice of gastroenterology.)\n##\n(\"entity\"<|>LUIZ MIGUEL LUENGO PÉREZ<|>PERSON<|>Luis Miguel Luengo Pérez is a researcher or author associated with the topic of nutritional support in amino acid metabolism disorders.)\n##\n(\"entity\"<|>GLUTEN-FREE DIET<|>EVENT<|>A gluten-free diet is a dietary regimen that excludes gluten, which is found in wheat, barley, and rye, and is essential for managing celiac disease.)\n##\n(\"entity\"<|>GASTROENTEROLOGY<|>EVENT<|>Gastroenterology is a branch of medicine focused on the digestive system and its disorders.)\n##\n(\"relationship\"<|>CELIAC DISEASE<|>GLUTEN-FREE DIET<|>A gluten-free diet is the primary treatment for managing celiac disease and preventing its complications.<|>10)\n##\n(\"relationship\"<|>NATIONAL INSTITUTES OF HEALTH<|>CELIAC DISEASE<|>The National Institutes of Health has conducted research and published consensus statements regarding the diagnosis and management of celiac disease.<|>8)\n##\n(\"relationship\"<|>AGA INSTITUTE<|>CELIAC DISEASE<|>The AGA Institute provides guidelines and medical position statements on the diagnosis and management of celiac disease.<|>8)\n##\n(\"relationship\"<|>LUIZ MIGUEL LUENGO PÉREZ<|>GASTROENTEROLOGY<|>Luis Miguel Luengo Pérez is involved in research related to gastroenterology, particularly in the context of amino acid metabolism disorders.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 303\n\n7. Shan, L, Molberg, O, Parrot, I, et al. Structural ba-\n   sis for gluten intolerance in celiac sprue. Science\n   2002; 297:2275.\n8. Fasano A, Sapone A, Zevallos V, Schuppan D.\n   Nonceliac gluten sensitivity. Gastroenterology.\n   2015 May;148(6):1195-204.\n9. Ferguson, A, Arranz, E, O'Mahoney, S. Clinical and\n   pathological spectrum of coeliac disease-active,\n   silent, latent, potential. Gut 1993; 34:150.\n10. Goddard CJ, Gillett HR. Complications of coeliac\n    disease: are all patients at risk? Postgrad Med J.\n    2006 Nov;82(973):705-12.\n11. McKinley, M, Leibowitz, S, Bronzo, R, et al. Appro-\n    priate response to pneumococcal vaccine in celiac\n    sprue. J Clin Gastroenterol 1995; 20:113.\n12. Han Y, Chen W, Li P, Ye J. Association Between\n    Coeliac Disease and Risk of Any Malignancy and\n    Gastrointestinal Malignancy: A Meta-Analysis.\n    Medicine (Baltimore). 2015 Sep;94(38):e1612.\n13. Cosnes, J, Cellier, C, Viola, S, et al. Incidence of\n    autoimmune diseases in celiac disease: protective\n    effect of the gluten-free diet. Clin Gastroenterol\n    Hepatol 2008; 6:753.\n14. Marciano F, Savoia M, Vajro P. Celiac disease-rela-\n    ted hepatic injury: Insights into associated condi-\n    tions and underlying pathomechanisms. Dig Liver\n    Dis. 2016 Feb;48(2):112-9\n15. Ackerman, Z, Eliakim, R, Stalnikowica, R, Rachmi-\n    lewitz, D. Role of small bowel biopsy in the endos-\n    copic evaluation of adults with iron deficiency\n    anemia. Am J Gastroenterol 1996; 91:2099.\n16. Heikkilä K, Pearce J, Mäki M, Kaukinen K. Celiac\n    disease and bone fractures: a systematic review\n    and meta-analysis. J Clin Endocrinol Metab. 2015\n    Jan;100(1):25-34.\n\n17. Kagnoff, MF.AGA Institute Medical Position State-\n    ment on the Diagnosis and management of Celiac\n    Disease. Gastroenterology. 2006 Dec;131(6):1977-\n    80.\n18. National Institutes of Health Consensus Develop-\n    ment Conference Statement. Celiac Disease 2004.\n    Gastroenterology. 2005 Apr;128(4 Suppl 1):S1-9.\n    Disponible en http://consensus.nih.gov\n19. Askling, J, Linet, M, Gridley, G, et al. Cancer inci-\n    dence in a population-based cohort of individuals\n    hospitalized with celiac disease or dermatitis her-\n    petiformis. Gastroenterology 2002; 123:1428.\n20. Niewinski,M. Advances in Celiac Disease and Glu-\n    ten-Free Diet. J Am Diet Assoc. 2008;108:661-\n    672.\n21. Pietzak MM. Follow-up of patients with celiac di-\n    sease: Achieving compliance with treatment. Gas-\n    troenterology. 2005;128(suppl 1): S135-S141.\n22. Scott, EM, Gaywood, I, Scott, BB. Guidelines for\n    osteoporosis in coeliac disease and inflammatory\n    bowel disease. British Society of Gastroenterology.\n    Gut 2000; 46 Suppl 1:11.\n23. The Gluten-Free Certification Organization. http://\n    www.gfco.org. Accessed December 22, 2008.\n24. Lee, SK, Lo, W, Memeo, L, et al. Duodenal histolo-\n    gy in patients with celiac disease after treatment\n    with a gluten-free diet. Gastrointest Endosc 2003;\n    57:187.\n25. Abdulkarim, AS, Burgart, LJ, See, J, Murray, JA.\n    Etiology of nonresponsive celiac disease: Results of\n    a systematic approach. Am J Gastroenterol 2002;\n    97:2016.\n26. Al-Toma A, Verbeek WH, Mulder CJ. Update on\n    the management of refractory coeliac disease [re-\n    view]. J Gastrointestin Liver Dis. 2007; 16:57-63.\n---\nThe image appears to be a blank white page. There is no visible content, text, diagrams, or any other information present in this image. Therefore, I cannot provide any markdown translation or description of content, as there is nothing to transcribe or describe.\n---\n# Tema 18.\n## Soporte nutricional en metabolopatías de los aminoácidos. Fenilcetonuria, homocistinuria, enfermedad de orina de jarabe de arce y trastornos del ciclo de la urea. Glucogenosis\n\nLuis Miguel Luengo Pérez\nUn\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}